Literature DB >> 34978848

Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cutaneous T Cell Lymphoma.

Jennifer A Salant1, Niloufer Khan2,3, Judith E Nelson3,4,5, Moe Norton-Westbrook4, Anjali V Desai3,4.   

Abstract

Cutaneous T cell lymphoma and its subtypes, mycosis fungoides (MF) and Sézary syndrome (SS), comprise a spectrum of chronic lymphoproliferative disorders in which neoplastic T cells accumulate within the skin and visceral organs. This process is frequently characterized by severe pain, nonpain symptoms, and physical disfigurement. Significant emotional, spiritual, and existential distress is also felt by many of these patients as they experience a chronic, often incurable disease. Patients suffering from these diseases, though not commonly encountered, can benefit greatly from palliative care support. In this article, a team of palliative care clinicians, critical care physicians, and an oncologist specializing in lymphoma offer 10 tips to help palliative care teams to support these vulnerable and often-distressed patients and their caregivers.

Entities:  

Keywords:  Sézary syndrome; cutaneous T cell lymphoma; mycosis fungoides

Mesh:

Year:  2021        PMID: 34978848      PMCID: PMC9467632          DOI: 10.1089/jpm.2021.0610

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  37 in total

1.  Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients.

Authors:  H S Zackheim; S Amin; M Kashani-Sabet; A McMillan
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

2.  Strategies for treating cutaneous T-cell lymphoma: part 1: remission.

Authors:  Jo-Ann Latkowski; Peter Heald
Journal:  J Clin Aesthet Dermatol       Date:  2009-06

Review 3.  Mycosis Fungoides and Sézary Syndrome: An Update.

Authors:  Cecilia Larocca; Thomas Kupper
Journal:  Hematol Oncol Clin North Am       Date:  2019-02       Impact factor: 3.722

4.  Changing incidence trends of cutaneous T-cell lymphoma.

Authors:  Kaveri Korgavkar; Michael Xiong; Martin Weinstock
Journal:  JAMA Dermatol       Date:  2013-11       Impact factor: 10.282

5.  Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

Authors:  K Molloy; C Jonak; F J S H Woei-A-Jin; E Guenova; A M Busschots; A Bervoets; E Hauben; R Knobler; S Porkert; C Fassnacht; R Cowan; E Papadavid; M Beylot-Barry; E Berti; S Alberti Violetti; T Estrach; R Matin; O Akilov; L Vakeva; M Prince; A Bates; M Bayne; R Wachsmuch; U Wehkamp; M Marschalko; O Servitje; D Turner; S Weatherhead; M Wobser; J A Sanches; P McKay; D Klemke; C Peng; A Howles; J Yoo; F Evison; J Scarisbrick
Journal:  Br J Dermatol       Date:  2019-07-28       Impact factor: 9.302

6.  Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Authors:  Nita Sally Agar; Emma Wedgeworth; Siobhan Crichton; Tracey J Mitchell; Michael Cox; Silvia Ferreira; Alistair Robson; Eduardo Calonje; Catherine M Stefanato; Elizabeth Mary Wain; Bridget Wilkins; Paul A Fields; Alan Dean; Katherine Webb; Julia Scarisbrick; Stephen Morris; Sean J Whittaker
Journal:  J Clin Oncol       Date:  2010-09-20       Impact factor: 44.544

Review 7.  Cutaneous T-cell lymphoma: overview and nursing perspectives.

Authors:  Sue A McCann
Journal:  Nurs Clin North Am       Date:  2007-09       Impact factor: 1.208

8.  Incidence and survival patterns of cutaneous T-cell lymphomas in the United States.

Authors:  Muhammad Hassaan Imam; Pareen J Shenoy; Christopher R Flowers; Adrienne Phillips; Mary Jo Lechowicz
Journal:  Leuk Lymphoma       Date:  2013-01-07

Review 9.  Infantile-onset cutaneous T-cell lymphoma.

Authors:  A Tsianakas; A K Kienast; P H Hoeger
Journal:  Br J Dermatol       Date:  2008-08-19       Impact factor: 9.302

10.  Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.

Authors:  T S Bhat; C M Herbosa; A R Rosenberg; O Sogade; D B Jeffe; N Mehta-Shah; Y R Semenov; A C Musiek
Journal:  Br J Dermatol       Date:  2020-08-02       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.